RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
about
IkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activationActivation of RelA homodimers by tumour necrosis factor alpha: a possible transcriptional activator in human vascular endothelial cellsI kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA bindingPurification of the major histocompatibility complex class I transcription factor H2TF1. The full-length product of the nfkb2 geneCloning of a differentially expressed I kappa B-related proteinA novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerizationNuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleusI kappa B alpha-mediated inhibition of v-Rel DNA binding requires direct interaction with the RXXRXRXXC Rel/kappa B DNA-binding motifPhysical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptorThe NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa BAbsolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytesBoth N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motifNF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like moleculeThe RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoproteinA novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B siteControl of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alphaTransdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplicationPost-Translational Modifications of RelB NF-κB Subunit and Associated FunctionsX-ray Structure of a NF-κB p50/RelB/DNA Complex Reveals Assembly of Multiple Dimers on Tandem κB SitesInteraction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivatorsNF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responsesPhosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa BCharacterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loopNF-kappa B subunit-specific regulation of the interleukin-8 promoterTax-1 and Tax-2 similarities and differences: focus on post-translational modifications and NF-κB activation.DNA binding alters the protease susceptibility of the p50 subunit of NF-kappa B.Members of the nuclear factor kappa B family transactivate the murine c-myb gene.RelB-dependent stromal cells promote T-cell leukemogenesisDeficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms.Integrating innate and adaptive immunity in the whole animal.Regulation of natural killer T-cell development by deubiquitinase CYLDRegulation of RelB expression during the initiation of dendritic cell differentiation.RelB modulation of IkappaBalpha stability as a mechanism of transcription suppression of interleukin-1alpha (IL-1alpha), IL-1beta, and tumor necrosis factor alpha in fibroblasts.N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.In vivo control of NF-kappa B activation by I kappa B alpha.Tilapia hepcidin 2-3 peptide modulates lipopolysaccharide-induced cytokines and inhibits tumor necrosis factor-alpha through cyclooxygenase-2 and phosphodiesterase 4DBovine foamy virus transactivator BTas interacts with cellular RelB to enhance viral transcription
P2860
Q24290171-D6C05C65-9B2F-4F78-AAE8-D21CAD5F141BQ24293705-DDBCF3AD-9F18-47D1-A0D3-37DFB3A1BD93Q24301448-0526E26F-E159-4AA6-B9FE-F5576A254F48Q24307786-4B91544F-BE70-4F6B-8972-9DEE5FE209C2Q24312701-545EA51B-C050-4D52-9BF7-E6A8FD871830Q24316435-A5681D1B-8DCD-4C65-BD60-94F51274BD1EQ24320246-24CFDFCB-4C79-48E7-B3C4-F462A04DCA39Q24337591-4E779C4C-A215-4AAD-BA8F-BF09973B8C02Q24561403-834CE044-825E-47BE-B52B-FAAACFD511A0Q24561876-48A6935E-5E0A-49A7-A988-08C1E4B09935Q24564833-F14096FC-A677-4543-A983-16C5DDE5B657Q24568326-FE867B5A-98E3-4C7C-9C40-E946AF8407B6Q24606830-99D5D0E6-C421-41D1-B948-3D510DB248FDQ24629772-CFC2A90A-C173-4884-A31E-7F10948A23B9Q24630135-1CADEDDA-C541-4043-A960-E4D6519A52F7Q24630534-57D62723-9AE5-4088-9BF8-1FE847A0BBFBQ24676497-B72DE116-AB8D-4B94-A490-41DFCAD28656Q24681560-78E61821-FCFC-4F53-9299-528B64ACEE0EQ26751459-13BC85CD-9E31-4052-BB7E-B89D0CAAE1CEQ27648171-0D3C3340-026E-4B0B-85E6-0D9B0B9A2FA2Q28299369-EF2BF4A4-3A5B-46D3-9F94-49DE1DD97FE8Q28505819-35C65C66-E030-463E-9EC1-362F8A19183BQ28615823-51D0002D-3DAB-4A5B-B802-5DA90BE6481EQ28645865-3601A2D0-0AC7-428E-9475-212C7C795088Q28646361-EC3642FF-DA56-4045-9E69-401775303DA0Q30353061-A7C28ABF-694D-4407-8226-AF77830BD33AQ30421431-C5B45D17-4814-44FB-BC80-46FC91C78B40Q30464811-B0C655A5-3B2D-4FD7-BE38-1081F038BBE3Q33348553-7EB8A65F-38A8-42BA-8C2C-789D87748007Q33569314-8C1E91F3-D489-4771-8DF8-ED1F1A80A3BAQ33713343-EE0A15DF-2C95-47B7-A07A-A82A7BCF6C5CQ33878486-9A836296-C5D1-457E-BC05-80E8539473E2Q33925045-C3CC9F6C-D6DE-4106-9F80-C7A486A0516AQ33960289-F8B5F204-F716-451B-A1BC-6F68CCC0F9FEQ34041262-87EDC062-5633-4DAF-A7F7-D329E35E077BQ34059393-6AB8DBB2-E41A-4B7E-A290-63ACED72A324Q34061332-12F1FA1E-72D4-4F7D-9201-1F66E2EE6A6AQ34069959-F1BAB14A-5928-4AEE-9821-FEC0A538984CQ34155303-A7B92D02-862B-4824-8483-76B896FE856CQ34295911-25A00B17-79B9-4A60-AADC-E0444A238A78
P2860
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
@ast
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
@en
type
label
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
@ast
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
@en
prefLabel
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
@ast
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
@en
P2093
P2860
P356
P1476
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
@en
P2093
Dobrzanski P
Siebenlist U
Takamiya M
P2860
P304
P356
10.1128/MCB.12.2.674
P407
P577
1992-02-01T00:00:00Z